Brief: Venus Remedies gets market authorization for Meropenem from Switzerland
11/11/2014 06:45
Nov 11 (Reuters) - Venus Remedies Ltd VENR.NS : * Receives market authorization for meropenem from Switzerland * Source text:http://bit.ly/1tBhDkS * Further company coverage VENR.NS ((Bangalore Newsroom; +91 80 6749 1130))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage